Victory Capital Management’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-18,581
| Closed | -$172K | – | 2688 |
|
|
2022
Q4 | $172K | Sell |
18,581
-1,217
| -6% | -$11.2K | ﹤0.01% | 2289 |
|
|
2022
Q3 | $254K | Sell |
19,798
-1,233
| -6% | -$15.8K | ﹤0.01% | 2298 |
|
|
2022
Q2 | $278K | Buy |
21,031
+807
| +4% | +$10.7K | ﹤0.01% | 2261 |
|
|
2022
Q1 | $292K | Sell |
20,224
-45,947
| -69% | -$663K | ﹤0.01% | 2307 |
|
|
2021
Q4 | $1.59M | Buy |
66,171
+12,689
| +24% | +$305K | ﹤0.01% | 1642 |
|
|
2021
Q3 | $1.36M | Sell |
53,482
-4,956
| -8% | -$126K | ﹤0.01% | 1722 |
|
|
2021
Q2 | $1.97M | Sell |
58,438
-3,421
| -6% | -$115K | ﹤0.01% | 1638 |
|
|
2021
Q1 | $2.4M | Sell |
61,859
-15,069
| -20% | -$585K | ﹤0.01% | 1595 |
|
|
2020
Q4 | $4.76M | Buy |
76,928
+9,352
| +14% | +$579K | 0.01% | 1255 |
|
|
2020
Q3 | $2.26M | Sell |
67,576
-9,686
| -13% | -$324K | ﹤0.01% | 1406 |
|
|
2020
Q2 | $1.84M | Sell |
77,262
-327,864
| -81% | -$7.81M | ﹤0.01% | 1466 |
|
|
2020
Q1 | $9.28M | Buy |
405,126
+225,478
| +126% | +$5.16M | 0.01% | 1109 |
|
|
2019
Q4 | $5.09M | Buy |
179,648
+175,735
| +4,491% | +$4.98M | 0.01% | 1183 |
|
|
2019
Q3 | $84K | Buy |
3,913
+1,413
| +57% | +$30.3K | ﹤0.01% | 2491 |
|
|
2019
Q2 | $73K | Buy |
+2,500
| New | +$73K | ﹤0.01% | 1679 |
|